These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1806185)

  • 1. [IL 6 and lymphoproliferative diseases].
    Lévy Y; Brouet JC
    C R Seances Soc Biol Fil; 1991; 185(5):262-7. PubMed ID: 1806185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL6 and lymphoproliferative disorders.
    Brouet JC; Levy Y
    Nouv Rev Fr Hematol (1978); 1991; 33(6):433-6. PubMed ID: 1818294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interleukin 6 and lymphoplasmocytic proliferation].
    Brouet JC; Lévy Y
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):225-6. PubMed ID: 8337132
    [No Abstract]   [Full Text] [Related]  

  • 4. CD40 expression in malignant plasma cells. Role in stimulation of autocrine IL-6 secretion by a human myeloma cell line.
    Westendorf JJ; Ahmann GJ; Armitage RJ; Spriggs MK; Lust JA; Greipp PR; Katzmann JA; Jelinek DF
    J Immunol; 1994 Jan; 152(1):117-28. PubMed ID: 7504707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6 antisense oligonucleotides inhibit the growth of human myeloma cell lines.
    Levy Y; Tsapis A; Brouet JC
    J Clin Invest; 1991 Aug; 88(2):696-9. PubMed ID: 1864979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of interleukin 6 in multiple myeloma and bone marrow stromal cells.
    Chauhan D; Uchiyama H; Urashima M; Yamamoto K; Anderson KC
    Stem Cells; 1995 Aug; 13 Suppl 2():35-9. PubMed ID: 8520509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Growth characteristics of a human myeloma cell line transfected with IL-6 cDNA].
    Takahashi T; Okuno Y; Ohsugi Y
    Rinsho Ketsueki; 1993 Apr; 34(4):423-6. PubMed ID: 8510328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delineation of the roles of paracrine and autocrine interleukin-6 (IL-6) in myeloma cell lines in survival versus cell cycle. A possible model for the cooperation of myeloma cell growth factors.
    Jourdan M; Mahtouk K; Veyrune JL; Couderc G; Fiol G; Redal N; Duperray C; De Vos J; Klein B
    Eur Cytokine Netw; 2005; 16(1):57-64. PubMed ID: 15809207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [B lymphoproliferative syndrome with characteristics common to chronic lymphatic leukemia, Waldenström disease and plasmacytic leukemia].
    Tosato F; Fossaluzza V; Sala P; Tonutti E
    Minerva Med; 1984 Nov; 75(44):2691-4. PubMed ID: 6440066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma.
    Klein B; Zhang XG; Jourdan M; Boiron JM; Portier M; Lu ZY; Wijdenes J; Brochier J; Bataille R
    Eur Cytokine Netw; 1990; 1(4):193-201. PubMed ID: 2104241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pulmonary lymphoproliferative syndromes].
    Redón J; Perpiñá M; Abad F; Herranz C; Caballero M; Marco V
    Rev Clin Esp; 1982 Jan; 164(2):75-82. PubMed ID: 6806872
    [No Abstract]   [Full Text] [Related]  

  • 12. [Biology of interleukin-6. Role in lymphoplasmacytic hemopathies].
    Levy Y; Brouet JC
    Ann Med Interne (Paris); 1992; 143(8):533-43. PubMed ID: 1303597
    [No Abstract]   [Full Text] [Related]  

  • 13. Involvement of IL-10 in the autonomous growth of EBV-transformed B cell lines.
    Beatty PR; Krams SM; Martinez OM
    J Immunol; 1997 May; 158(9):4045-51. PubMed ID: 9126962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression.
    Westendorf JJ; Jelinek DF
    J Immunol; 1996 Oct; 157(7):3081-8. PubMed ID: 8816418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enforced expression of superoxide dismutase 2/manganese superoxide dismutase disrupts autocrine interleukin-6 stimulation in human multiple myeloma cells and enhances dexamethasone-induced apoptosis.
    Hodge DR; Xiao W; Peng B; Cherry JC; Munroe DJ; Farrar WL
    Cancer Res; 2005 Jul; 65(14):6255-63. PubMed ID: 16024627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of INTERLEUKIN-6 in the pathogenesis of multiple myeloma.
    Gadó K; Domján G; Hegyesi H; Falus A
    Cell Biol Int; 2000; 24(4):195-209. PubMed ID: 10816321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytokines and lymphoplasmocytic proliferations: essential role of interleukin 6].
    Bataille R; Klein B
    Rev Prat; 1993 Feb; 43(3):275-8. PubMed ID: 8502954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Signal transduction and biological function of IL-6 in a human myeloma cell line-XG-7].
    Song L; Shen B
    Zhonghua Yi Xue Za Zhi; 2000 Nov; 80(11):845-8. PubMed ID: 11218881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells.
    Wang YD; De Vos J; Jourdan M; Couderc G; Lu ZY; Rossi JF; Klein B
    Oncogene; 2002 Apr; 21(16):2584-92. PubMed ID: 11971193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenesis in Waldenstrom's macroglobulinemia.
    Rajkumar SV; Hayman S; Greipp PR
    Semin Oncol; 2003 Apr; 30(2):262-4. PubMed ID: 12720149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.